ReviewPathologie (Heidelberg, Germany)2025
[Grossing and reporting of the radical prostatectomy specimen].
Review in Pathologie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The grossing and reporting of radical prostatectomy specimens are key issues in pathology. Consensus conferences have defined clear guidelines for UICC/TNM-relevant parameters, while the extent of embedding remains controversial. Various embedding protocols, such as the Bonn protocol, enable efficient processing with consistent diagnostic significance. The increasing use of standardized diagnostic schemes, such as those developed by the International Collaboration on Cancer Reporting (ICCR), can ensure (international) comparability of diagnoses. This paper explains the criteria for embedding and reporting with a particular focus on prognostically relevant findings such as the differentiation between pT2 and pT3 tumors.
Indexed as
Identifiers
40205188What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.